Always up to date.
 

Our goal is to develop procedure and anatomy specific devices that lead in collaboration with our customers to predictable and superior treatment outcomes. Read on to learn more about our solutions, priorities, partnerships and how we create sustainable value with our teams.

Page 2 of 13.

Medartis successfully places CHF 115.8 million convertible bonds due 2031

Medartis Holding AG (SIX: MED, the “Company” or “Medartis”), a specialized orthopaedic company for head and extremity surgery, announces the successful placement of senior unsecured guaranteed...

Read more

Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%

Demonstrating further market share gains, full-year 2023 sales rose by 20.5%(CER) to CHF 212.0 million. The EMEA region was the driving force with strong growth of 19.8%, exceeding the CHF 100 million...

Read more

Publication of the Annual Report 2023

The integrated Annual Report 2023, consisting of the Management Report, the extended Sustainability Report, the Corporate Governance Report, the Remuneration Report and the Financial Report, can be...

Read more

Page 2 of 13.